There is hope for people living with multi-drug resistant tuberculosis (MDR-TB) as the “gruelling” two-year treatment with “terrible side-effects” such as deafness can now be successfully shortened to just nine months.
Almost 25 percent of health facilities surveyed nationally have gone without HIV or tuberculosis (TB) medicines at least once in the last year, according to preliminary survey results released this week.
Dozens of activists and patients picketed today outside the Johannesburg meeting of a United Nations high level panel on access to medicines. Activists have demanded governments fund more drug research and development.
The United Nations Secretary-General’s High-Level Panel on Access to Medicines is calling for proposals to enhance and strengthen the promotion of innovation and access to medicines, vaccines and diagnostics.
After months of erratic supply of its antiretroviral (ARV) Aluvia in South Africa, international pharmaceutical company AbbVie will now allow generic manufacturers to produce the drug to help safeguard supplies, according to an announcement made today.
No one knows how many South Africans are living with hepatitis C but the virus affects everyone from injecting drug users to suburban housewives. For decades, Hep C treatment was priced out of reach. Now, South Africa is importing new, better and cheaper drugs but a cure still comes at a cost.
In an effort to combat medicine shortages, South Africa will roll out a first of its kind early warning system to identify drug stock outs before they happen. See what else the country is doing to keep pills in patients’ hands.
In an effort to combat medicine shortages, South Africa will roll out a first of its kind early warning system to identify drug stock outs before they happen. The move comes as country and makers of the antiretroviral Aluvia work to address shortages